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Abstract
Objective: Although cancer patients frequently experience self-perceived burden to others, this percep-
tion has not been enough studied. The aim of this study was to investigate the prevalence of self-
perceived burden to the primary caregiver (SPB-PC) and associated factors in an older patient
population with hematologic malignancies at the time of chemotherapy initiation.
Methods: In total, 166 consecutive patients with hematologic malignancies aged ≥65 years were
recruited at the time of chemotherapy initiation. Patients’ SPB-PC was assessed using a 100-mm visual
analogue scale (VAS). Characteristics potentially associated with SPB-PC, including sociodemographic
and medical characteristics, physical functioning status (Karnofsky performance score, activities of
daily living (ADL)/instrumental ADL), symptoms (fatigue, pain, nausea, quality of life), psychological
distress (Hospital Anxiety and Depression Scale (HADS)), perceived cognitive function (Functional
Assessment of Cancer Therapy Cognitive (FACT-Cog) Scale), and patients’/primary caregivers’
personal relationship characteristics (family tie, support), were assessed.
Results: Thirty-ﬁve percent of patients reported moderate to severe SPB-PC (VAS ≥ 50 mm).
Patients’ SPB-PC was associated with lower Karnofsky performance (β =0.135, p= 0.058) and
ADL (β =0.148, p= 0.037) scores, and higher HADS (β = 0.283, p< 0.001) and FACT-Cog perceived
cognitive impairments subscale (β = 0.211, p= 0.004) scores. The proportion of explained variance was
23.5%.
Conclusions: Health care professionals should be aware that about one third of older cancer pa-
tients experience moderate to severe SPB-PC at the time of chemotherapy initiation. They should
adapt their support of patients who report such a feeling.
Copyright © 2016 John Wiley & Sons, Ltd.
Introduction
Patients with chronic illness frequently worry about being
a burden to their families [1]. Although burden has been
investigated from the caregiver’s perspective [2–7], few
studies have addressed patients’ feeling of being a burden.
Patients’ self-perceived burden (SPB) refers to ‘an em-
pathic concern engendered from the impact on others of
one’s illness and care needs, resulting in guilt, distress,
feelings of responsibility, and diminished sense of self’
[8] (p425). SPB can have major consequences on patients’
decision making, leading them to choose not to initiate
treatment [9], refuse life-extending medical treatment
[10], experience a diminished will to live [11], desire has-
tened death [12,13], and/or prefer to receive end-of-life
care in an institutional setting, rather than at home [14,15].
Patients’ SPB may develop for various reasons. It may
appear among subjects with functional limitations,
reﬂecting social standards and ideals promoting auton-
omy, productivity, and successful aging [16]. It may arise
from an imbalance between what a patient can contribute
and what he or she receives in return when perceived pos-
sibilities to reduce the imbalance are limited or nonexis-
tent [17,18]. Patients’ SPB may also arise from the
internalization of different types of social norms and
values regarding relationships with others [19].
To our knowledge, SPB has rarely been studied in on-
cology, except in the context of palliative care. One study
demonstrated that 65% of patients with advanced cancer
experienced minimal SPB and 19% experienced moderate
to extreme SPB [20]. Other studies have been conducted
among patients with chronic pain or terminal illness to
Copyright © 2016 John Wiley & Sons, Ltd.
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assess factors associated with SPB [21–23]. Among
sociodemographic characteristics, an association was found
with living only with a spouse (suggesting a higher SPB
when patients lived only with their spouse versus only with
other family members versus with their spouse and with
other family members) [24], whereas associations with
age, gender, marital status, and education level have often
been contradictory or absent [21–25]. Among psychologi-
cal characteristics, patients’ SPB has been correlated with
psychological distress [26], depression, worry about the
future, decreased ability to concentrate [21], poor per-
ceived quality of life (QOL) [22], loss of control, loss of
dignity, hopelessness [25], and suicidal ideation [27,28].
Associated medical characteristics include a large number
of comorbid conditions [22] and the presence of physical
symptoms, such as pain, weakness, dyspnea [25], and
functional limitation [23,29]. One study found no associa-
tion between physical symptoms and SPB among termi-
nally ill patients [21]; the authors suggested that the
impact of physical symptoms on SPB may have been
outweighed by psychological discomfort. Among relation-
ship characteristics, patients’ SPB has been associated with
greater caregiver burden [23].
Available studies addressing patients’ SPB have meth-
odological limitations. They have been conducted as case
studies [30], and they have focused mainly on patients
with terminal [30,31] or chronic [23,32] illness. Thus,
the conclusions of these studies are not generalizable to
other medical settings. Moreover, the persons to which
patients refer when reporting SPB (primary caregiver
versus others) have not been identiﬁed systematically.
SPB of older patients with cancer requires the attention
of researchers and health care professionals for several
reasons. First, older patients with cancer are potentially
at greater risk of being a burden to their family and friends
for long periods of time, considering their frequent loss of
autonomy, physical and psychological discomfort, and
frailties. Second, SPB may be a factor triggering suicide,
which is frequent among older patients with cancer [33].
Third, as SPB has been shown to inﬂuence medical deci-
sion making, it must be better addressed in settings
devoted to the care of older patients with cancer. Knowl-
edge about SPB is important to improve the quality of
support provided by health care professionals.
The aim of this study was to assess the prevalence of
self-perceived burden to the primary caregiver (SPB-PC)
in older patients with hematologic malignancies at the
time of chemotherapy initiation. First, it has been chosen
to look speciﬁcally to SPB-PC to study a precise subjec-
tive feeling which may be useful to consider in patients
and their primary caregivers support. Second, the time of
chemotherapy initiation was chosen because patients were
considered by physicians to be sufﬁciently ﬁt for the initi-
ation of a new treatment, and their treatment response
could be considered as a possible positive outcome. The
treatment initiation period was thus considered suitable
for the assessment of SPB-PC and associated factors to
optimize support provided to patients and caregivers.
Third, although there is not a strong rationale to study
speciﬁcally a hematological population, such a population
– versus a population presenting solid tumors – was con-
sidered for the purpose of this study as illness perception
and symptoms burden may be speciﬁc [34]. Given the
current lack of models to explain SPB-PC in older patients
with cancer, we conducted exploratory analyses to assess
associations with patient and patients’/primary caregivers’
personal relationship characteristics. Most of factors




This study was conducted in six Belgian hospitals and was
approved by the local ethics committee. All consecutive
patient volunteers fulﬁlling the inclusion criteria were
invited to participate and provided written informed con-
sent. Recruited patients were aged ≥65 years, had hemato-
logic malignancies, had been admitted for chemotherapy
initiation, and were able to speak French. Patients hospi-
talized for palliative care, those with diagnoses of severe
dementia, and those who could not complete scheduled
assessments for physical or psychological reasons were
excluded. The assessment conducted by several indepen-
dent investigators was conducted during the 48 h around
chemotherapy initiation and lasted approximately 1 – 1.5 h.
Therefore the assessment might have been conducted after
the chemotherapy initiation. In order to avoid bias,
self-reported questionnaires were used. Moreover the in-
vestigators were trained in order to standardize the way
to present the study and the assessment. Considering the
requirements of the local ethics committee, no information
on non-respondents was collected.
Assessment tools
Self-perceived burden to the primary caregiver
As the study was run in French, the use of a 100-mm vi-
sual analogue scale (VAS; ranging from ‘not at all’ to ‘a
lot’) was chosen in order to minimize cross-languages or-
dinal and interval differences of response choices of a 5-
point Likert scale.
Patients’ sociodemographic and medical characteristics
Patients provided demographic information, including
age, gender, educational level, marital status, and living
status. Physicians provided patients’ medical characteris-
tics including diagnosis, time since diagnosis, disease
status, prognosis, and number of comorbidities. Such as
Y. Libert et al.
Copyright © 2016 John Wiley & Sons, Ltd. Psycho-Oncology (2016)
DOI: 10.1002/pon
SPB-PC, VAS assessing patients’ symptoms were used
ﬁrstly to minimize cross-languages ordinal and interval
differences of response choices and second to avoid a
too long assessment period. Four VAS were used in order
to assess current patients’ levels of fatigue (ranging from
‘not at all’ to ‘a lot’), pain (ranging from ‘not at all’ to
‘a lot’), nausea (ranging from ‘not at all’ to ‘a lot’), and
QOL (ranging from ‘very bad’ to ‘excellent’).
Patients’ physical functioning status and psychological
characteristics
Patients’ physical functioning status and psychological
characteristics were assessed using validated tools:
Karnofsky performance score, activities of daily living
(Katz ADL [35] (total score ranged from 6 to 24) and
Lawton IADL [36] (total score ranged from 8 to 32);
higher score indicated better physical functioning status),
Functional Assessment of Cancer Therapy Cognitive
Scale version 3 (FACT-Cog), Hospital Anxiety and De-
pression Scale (HADS; higher score indicated higher psy-
chological distress) [37]. As most of these tools are well
known, only the FACT-Cog Scale will be detailed here.
The FACT-Cog Scale is a self-reported measure of cog-
nitive impairments and its impact on patients QOL. This
37-item instrument assesses patients’ memory, attention,
concentration, language, and thinking abilities during the
last 7 days. It consists of four subscales: perceived cogni-
tive impairments (20 items; score range 0–80; higher score
indicated frequent perceived impairments) and comments
from others (4 items; score range 0–16; higher score indi-
cated frequent comments from others) subscales; and per-
ceived cognitive abilities (9 items; score range 0–36;
higher score indicated higher perceived cognitive abilities)
and impact on QOL (4 items; score range 0–16; higher
score indicated higher impact on QOL) subscales [38].
The FACT-Cog questionnaire has been translated into
French and validated with French-speaking patients with
cancer [39].
Patients’/primary caregivers’ personal relationship
characteristics
Patients were asked to characterize their personal ties with
primary caregivers and to report the frequency of encoun-
ters (responses were grouped into two categories (a) ‘less
than every day’ versus (b) ‘every day’), frequency of dis-
cussions about the disease (responses were grouped into
two categories (a) ‘never, rarely or sometimes’ versus
(b) ‘often or always’), frequency with which the primary
caregiver helped the patient (responses were grouped into
two categories (a) ‘never, rarely or sometimes’ versus (b)
‘often or always’) and assessment of the primary care-
giver’s ability to perceive the patient’s difﬁculties (re-
sponses were grouped into two categories (a) ‘excellent,
very good or good’ versus (b) ‘average or poor’).
Statistical analysis
There is no available recommendation on how to consider
moderate to severe SPB-PC. Therefore, to assess the prev-
alence of moderate to severe SPB-PC, a cut-off score of
≥50 mm was chosen to consider a probably clinically
signiﬁcant SPB-PC. To assess associated factors, SPB-PC
was considered as a continuous variable. Univariate rela-
tionships between patient characteristics and SPB-PC
were evaluated using non-parametric tests (e.g. Spearman
correlations, Mann–Whitney or Kruskal–Wallis test). All
tests were two tailed and alpha was set at 0.05. A back-
ward stepwise linear regression model was then computed
to assess relationships between potential predictors
and patients’ SPB-PC. All variables with univariate
p-values≤0.05 were entered into the model. Variables
were not entered in the model as separate blocks and no
logtransformation was needed. Analyses were performed




Among 293 eligible inpatients, 98 refused to take part in the
study. Performance status of patients who refused to take
part to a time consuming assessment well described in the
consent form was certainly lower than the performance
status of included patients. Twenty patients withdrew from
assessments for various reasons: three patients considered
the duration of the assessment as too long, eight patients
considered not being physically able to continue the assess-
ment, three patients considered not being psychologically
able to continue the assessment, four patients gave other
reasons (personal reasons …). The two last patients gave
multiple reasons (duration of evaluation and physical state
versus physical, psychological state and other). Nine pa-
tients were excluded from statistical analyses because they
did not identify their primary caregiver. Thus, analyses in-
cluded 166 patients who could be admitted in day care or
inpatients settings according to their diagnosis and treat-
ments. Table 1 lists patients’ sociodemographic, medical,
physical functioning status, and psychological (SPB-PC,
psychological distress, perceived cognitive function)
characteristics.
Prevalence of self-perceived burden to the primary
caregiver (SPB-PC)
At the start of chemotherapy, 35% of participants experi-
enced moderate to severe SPB-PC (VAS≥50 mm). The
mean VAS score for the total sample (35 mm;
Std=35 mm) indicated clinically signiﬁcant SPB-PC,
with 19% of participants scoring in the highest quarter
(75–100 mm), 16% in the third quarter (50–74 mm),
Self-perceived burden in older cancer patients
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15% in the second quarter (25–49 mm), and 22% in the
lowest quarter (1–24 mm). Twenty-eight percent of pa-
tients reported no SPB-PC.
Factors associated with SPB-PC
Table 2 displays sociodemographic and medical charac-
teristics associated with patients’ SPB-PC at the start
of chemotherapy. Correlations between SPB-PC and
Table 1. Characteristics of older patients with cancer (n= 166)







Single, divorced, separated, or widowed 43 26
Married 123 74
Educational level
Junior high school or less 104 63
High school graduation or more 62 37
Living status
Living alone 39 23
Not living alone 127 76
Medical characteristics
Diagnosis
Lymphoma, multiple myeloma, chronic
lymphocytic leukemia
131 79
Acute myelogenous leukemia, chronic
myelomonocytic leukemia, myelodysplasia
29 17
Acute lymphocytic leukemia 6 4
Months since diagnosis 22 46
Disease status
Complete remission, partial remission,
minor remission or no change
16 10
In progression 28 17
Too early to evaluate 122 73
Prognosis
<1 year 9 5
≥1 year 58 35
Too early to evaluate 99 60
Number of comorbidities 3 2
Treatments
Chemotherapy 154 93
Autologous bone marrow transplant 8 5





Quality of life 63 27
Physical functioning status
Karnofsky performance score 81 15
Activities of daily living 24 1
Instrumental activities of daily living 31 1
Psychological characteristics
Psychological distress2* 12 7
Perceived cognitive function3
Perceived cognitive impairments 11 12
Comments from others 0.38 1
Perceived cognitive abilities 25 7
Impact on quality of life 3 4
Self-perceived burden to the
primary caregiver1
35 35
Abbreviation: Std, standard deviation; VAS, visual analogue scale.
1Assessed on a visual analogue scale (100 mm).
2Hospital Anxiety and Depression Scale.
3Functional Assessment of Cancer Therapy Cognitive Scale.
*Missing data for one patient.
Table 2. Sociodemographic and medical characteristics associated
with self-perceived burden to the primary caregiver among older
patients with cancer (Mann–Whitney test, Kruskal–Wallis test or
Spearman rho as appropriate; n= 166)
Self-perceived burden to the
primary caregiver (100-mm VAS)







Single, divorced, separated, or widowed 37 37
Married 34 34
Educational level 0.418
Junior high school or less 34 35
High school graduation or more 36 34
Living status 0.897
Living alone 36 36










Acute lymphocytic leukemia 23 35
Months since diagnosis 0.06 0.444
Disease status 0.506
Complete remission, partial remission,
minor remission or no change
38 34
In progression 38 31
Too early to evaluate 33 36
Prognosis 0.158
<1 year 37 37
≥1 year 32 32
Too early to evaluate 36 36
Number of comorbidities 0.10 0.219
Treatments 0.547
Chemotherapy 35 35
Autologous bone marrow transplant 46 40





Quality of life 0.33 <0.001
Abbreviation: Std, standard deviation; VAS, visual analogue scale.
1Assessed on a visual analogue scale (100 mm).
Y. Libert et al.
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sociodemographic characteristics were not signiﬁcant.
Among medical characteristics, only symptoms (fatigue,
pain, nausea, and QOL) were correlated signiﬁcantly
with SPB-PC (r=0.16 to 0.33).
Table 3 lists physical functioning status, psychological,
and patient/primary caregiver relationship characteristics
associated with SPB-PC. All physical functioning and
psychological variables were correlated signiﬁcantly
(r=0.18 to 0.41). Some data (HADS) were missing for
only one patient. No signiﬁcant association with relation-
ship characteristics was found.
The backward stepwise linear regression analysis in-
cluded 12 variables: psychological distress, perceived
cognitive impairment, comments from others, perceived
cognitive ability, impact of impairments on QOL,
QOL, pain, fatigue, nausea, Karnofsky performance
score, ADL and IADL scores. Older patients’ SPB-PC
was associated with low Karnofsky performance score
(β=0.135, p=0.058), difﬁculties in ADL (β=0.148,
p=0.037), psychological distress (β=0.283, p<0.001),
and perceived cognitive impairments (β=0.211, p=0.004).
The proportion of explained variance was 23.5% (Table
4). The results remain the same if the 12 patients receiving
bone marrow transplant are not included in the analysis.
It should be underlined that commonly Karnofsky perfor-
mance score is grouped into 100/70/40 and ADL/IADL
scores are categorized into dependency and independency.
In order to assess the linearity assumption of these scores,
we conducted a further linear regression model with
Karnofsky performance score and ADL/IADL scores as cat-
egorical variables according to the hereabove recommended
categorical scores. Results considering Karnofsky perfor-
mance score and ADL/IADL scores as categorical variables
are quite similar to results considering the scores as contin-
uous variables. It was therefore decided to include these
variables in the regression analysis as continuous variables.
Finally several logistic regression analyses were conducted
to test the output. The results are quite similar to the linear
regression results.
Conclusions
This study showed that 35% of older patients with hemato-
logic malignancies experienced moderate to severe SPB-
PC (VAS≥50 mm), and that higher levels of SPB-PC were
associated with increased functional and psychological dif-
ﬁculties. By contrast, SPB-PC was not associated with pa-
tients’ medical or patients’/primary caregivers’ personal
relationship characteristics. The examined characteristics
were associated weakly with SPB-PC, explaining about
25% of the variance. These results suggest that SPB-PC
is associated with characteristics that were not assessed in
this study. This study is the ﬁrst to show that about one
third older patients with cancer experience moderate to
severe SPB-PC prior to the side effects of chemotherapy.
Table 3. Functional autonomy, psychological, and relationship
characteristics associated with self-perceived burden to the primary
caregiver among older patients with cancer (Mann–Whitney test or
Spearman rho as appropriate; n= 166)
Self-perceived burden to the
primary caregiver (100-mm VAS)
Mean Std Rho p
Physical functioning status
Karnofsky performance score 0.24 0.002
Activities of daily living 0.23 0.003
Instrumental activities of daily living 0.24 0.002
Psychological characteristics
Psychological distress1* 0.41 <0.001
Perceived cognitive function2
Perceived cognitive impairments 0.29 <0.001
Comments from others 0.18 0.024
Perceived cognitive abilities 0.23 0.003






Frequency of encounters3 0.668
Less than every day 37 35




Never, rarely, or sometimes 30 33
Often or always 40 36
Frequency of caregivers’ support3 0.435
Never, rarely, or sometimes 31 33
Often or always 37 35
Caregivers’ ability to perceive
patients’ difﬁculties3
0.766
Very good, excellent, or good 34 33
Average or poor 35 35
Abbreviation: VAS, visual analogue scale.
1Hospital Anxiety and Depression Scale.
2Functional Assessment of Cancer Therapy Cognitive Scale.
3As reported by patients.
*Missing data for one patient.
Table 4. Characteristics associated with self-perceived burden to
the primary caregiver among older patients with cancer (linear
regression model, n= 165)
Self-perceived burden to the
primary caregiver (100-mm VAS)
β p
Physical functioning status
Karnofsky performance score 0.135 0.058
Activities of daily living 0.148 0.037
Psychological characteristics
Psychological distress 0.283 <0.001
Perceived cognitive impairments 0.211 0.004
Abbreviation: VAS, visual analogue scale.
Proportion of explained variance: 23.5%.
Self-perceived burden in older cancer patients
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This study conﬁrms the results of previous studies con-
ducted among patients with chronic pain or terminally
illness [21,23,26] by showing that older patients with can-
cer who feel functionally or psychologically impaired may
also experience SPB-PC. Participants did not report severe
functional, psychological, and cognitive difﬁculties. Thus,
even slight loss of physical functioning status and/or psy-
chological or cognitive difﬁculties at the time of chemo-
therapy initiation may be associated with SPB-PC in
older patients with cancer.
Surprisingly, we found no association between SPB-PC
and the medical characteristics examined. These results
may be explained by patients’minimization of the meaning
of this type of characteristics, and their expectation that the
planned treatment would be effective. Moreover, SPB-PC
was not associated with patients’/primary caregivers’
personal relationship characteristics examined in this study
(e.g. family tie, frequency of encounters, frequency of
discussions about difﬁculties, frequency of caregivers’
support, caregivers’ ability to perceive patients’ difﬁculties).
Our results have several clinical implications. Health
care professionals should be aware that more than one in
three older patients may experience moderate to severe
SPB-PC at the time of chemotherapy initiation. Profes-
sionals should thus be ready to address older patients’
SPB, even when they are starting new treatment, and
assess underlying factors and consequences in terms of
patients’ adjustment to treatment and everyday life. When
appropriate, health care professionals should also normal-
ize this feeling and adapt their support to the needs of
patients and caregivers.
In case of severe SPB-PC with adverse effects on med-
ical decision making, support interventions led by special-
ized mental health professionals and designed for older
patients with cancer should be available and offered. To
our knowledge, no recommendation has been designed
to speciﬁcally support patients experiencing SPB. Poten-
tially useful strategies that could be considered in the
development of psychological interventions to support
patients’ ability to cope with SPB [8] include inviting pa-
tients to take more active roles in their care, prepare them-
selves for future life steps, recognize the needs of others,
and increase aware of caregivers’ desire to help. These in-
terventions should thus also consider facilitating commu-
nication between patients and primary caregivers to
reduce the potential feeling of inequity.
To conclude, this study is the ﬁrst to assess the preva-
lence of moderate to severe SPB-PC exclusively in older
patients with cancer at the time of chemotherapy initia-
tion, and to explore characteristics associated with this
feeling. The results indicate that SPB-PC is prevalent
and may appear even in the initiation of treatment phase,
suggesting that SPB-PC should be assessed and ad-
dressed. Future studies should involve more precise inves-
tigation of other factors potentially underlying SPB-PC,
such as perceived efﬁcacy of treatment, ﬁnancial difﬁcul-
ties, primary caregivers’ distress, reciprocity, inequity,
guilt, values, social norms, self-esteem, personality traits
and past history. Further research should also investigate
the effects of SPB-PC on outcomes such as medical deci-
sion making, treatment compliance, and place of care in
older patients with cancer. Finally future studies should
also investigate similarities and differences in patients’
and primary caregivers’ reports of SPB-PC. The results
of such studies may allow to better understand the family
caregivers’ perception and may be helpful to organize the
support of patient/primary caregiver dyad.
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